Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

Milestone reached in Genome Therapeutics/Schering-Plough alliance

Feb. 27, 1998

Fujisawa develops new inhibitors of NO production

Feb. 27, 1998

Ariflo possesses potent antiinflammatory activity, without GI side effects

Feb. 26, 1998

T-440: a new antiasthma drug candidate from Tanabe

Feb. 26, 1998

Animal study indicates efficacy of oral PAF antagonist in allergic rhinitis

Feb. 26, 1998

TRH ineffective as treatment for lung problems in premature infants

Feb. 25, 1998

First corticosteroid dry powder inhaler launched in the U.S.

Feb. 24, 1998

Evaluation of anti-IgE therapy in patients with seasonal allergic rhinitis

Feb. 24, 1998

TAU-284 awaiting approval in Japan

Feb. 23, 1998

Role of nonsteroidal antiinflammatory therapy in asthma

Feb. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...